Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stuart Linder

Plastic Surgery Beverly Hills, CA Medical Doctor

NPI 1699811455 CMS profile 349098

9675 Brighton Way, Ste. 420, Beverly Hills, CA 90210

Open in the dashboard

General payments

$14,483

131 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Stuart Linder of Beverly Hills, CA is reported in the CMS Open Payments database as having received $14,483 across 131 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,563 20
2024 General $1,960 18
2023 General $2,430 23
2022 General $1,081 22
2021 General $1,179 25
2020 General $284 9
2019 General $3,988 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stuart Linder
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Stuart Linder were reported at $3,563. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Stuart Linder Plastic Surgery median Middle half National median
2019 $3,988 $371 $122–$1,483 $163
2020 $284 $158 $52–$438 $114
2021 $1,179 $249 $87–$752 $132
2022 $1,081 $274 $102–$793 $149
2023 $2,430 $299 $113–$891 $160
2024 $1,960 $361 $124–$1,062 $164
2025 $3,563 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $5,555 42 payments
  2. TELA Bio, Inc. $4,266 22 payments
  3. AbbVie, Inc. $2,158 21 payments
  4. Mentor Worldwide LLC $1,320 27 payments
  5. Sientra, Inc. $478 10 payments
  6. Innocoll Incorporated $189 5 payments
  7. Becton, Dickinson and Company $186 2 payments
  8. RTI Surgical, Inc $177 1 payment
  9. Davol Inc. $155 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,238 123 payments
  2. Travel and Lodging $3,546 7 payments
  3. Gift $2,700 1 payment
Products named General payments · program years 2019–2025
  1. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $3,640 17 payments
  2. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $2,876 26 payments
  3. NATRELLE $2,849 5 payments
  4. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $1,813 32 payments
  5. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $1,520 12 payments
  6. MENTOR MemoryGel Resterilizable Gel Sizer $1,140 19 payments
  7. ALLODERM $1,117 8 payments
  8. REVOLVE $1,105 10 payments
  9. OviTex 2S $626 5 payments
  10. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $478 10 payments
  11. Other $1,027 18 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

131 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record